RECURRENT BLADDER UROTHELIAL CARCINOMA
Clinical trials for RECURRENT BLADDER UROTHELIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT BLADDER UROTHELIAL CARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT BLADDER UROTHELIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo targets tough bladder cancers
Disease control OngoingThis early-phase trial tests a combination of two drugs (erdafitinib and enfortumab vedotin) in about 24 people with advanced bladder cancer that has spread and has specific FGFR2/3 gene changes. The goal is to find the safest dose and see if the combo can shrink or stabilize the…
Matched conditions: RECURRENT BLADDER UROTHELIAL CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 17, 2026 00:28 UTC
-
New combo therapy shows promise for Tough-to-Treat bladder cancer
Disease control OngoingThis study tests whether adding the chemotherapy drug eribulin to the immunotherapy atezolizumab works better than atezolizumab alone for people with advanced bladder or urinary tract cancer who cannot take standard cisplatin chemotherapy. About 72 adults with cancer that has spr…
Matched conditions: RECURRENT BLADDER UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 17, 2026 00:26 UTC
-
Can a simple gene test predict who will beat bladder cancer?
Knowledge-focused OngoingThis study looks at whether certain genetic changes in tumors can help doctors know which patients with advanced bladder cancer will benefit from the immunotherapy drug nivolumab. Researchers are testing tumor samples for specific gene mutations and a protein called CXCL13. The g…
Matched conditions: RECURRENT BLADDER UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:02 UTC